Joseph Damond

Joseph Damond, Global Chair for Health at Edelman Global Advisory, guides clients through the global healthcare industry, leveraging a government relations career focused on healthcare, trade and innovation. Prior to joining EGA, Mr. Damond served as Deputy Chief Policy Officer and Executive Vice President for International Affairs at the Biotechnology Innovation Organization (BIO) where he developed the industry association’s global policy strategy on healthcare, economic and trade issues, and foreign government relations policy. Before his work at BIO, Mr. Damond served as Vice President for International Government Relations for Pfizer where he managed their international trade and commercial issues, including leading industry efforts to strengthen market access and intellectual property (IP) provisions in the U.S.-Korea Free Trade Agreement. Prior to Pfizer, he worked as deputy vice president for International Affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA) where he led Asia and global market access programs and developed the industry’s successful strategy for market IP and access provisions in the U.S.-Australia Free Trade Agreement. Mr. Damond also spent 16 years as a U.S. trade official and negotiator, including his position as Deputy Assistant U.S. Trade Representative for Asia and Pacific, where he was chief negotiator of the historic agreement re-establishing normal trade relations with Vietnam. He also served as Chair of the Committee for International Trade within the 21 country APEC forum, and was Special Economic Assistant to the U.S. Trade Representative (USTR), and Executive Director of the Generalized System of Preferences. Mr. Damond has degrees from Princeton and Georgetown universities, and authored the book, Give Trade a Chance: The Negotiation of the U.S.-Vietnam Bilateral Trade Agreement.